For example, Kitagori et al. [40] proposed a urine osteopontin N-half concentration as a novel biomarker related to kidney inflammation; however, more extensive clinical studies are needed to confirm its suitability in LN prediction. This evidence concerns the gene SPP1 and lobular neoplasia.